Home Latest Filings Latest Buys Latest Sells Institutions Derivatives Hot Buys Data Screener Email Alerts Insider Charts
AGLE - As of  05/31/24, 06:08:12 PM:   18 Insider Transactions.

Sector: Unknown    Industry: Unknown
Prev Close:$0.00  Avg Vol(3m): 0  P/E: 0.00  EPS: 0.00

Email this page to a friend.    Insider Transactions for AGLE

Buy/Sell* Filed Date Subject Symbol Acquirer Pct Owned Details
B 2020-10-26 16:36:29.0 Aeglea BioTherapeutics AGLE Point72 Asset Management 6.2% view
B 2020-06-09 11:45:56.0 Aeglea BioTherapeutics AGLE BCLS II Equity Opportunities 6.1% view
S 2020-05-08 10:58:44.0 Aeglea BioTherapeutics AGLE BlackRock Inc 4.3% view
B 2020-02-14 12:00:26.0 Aeglea BioTherapeutics AGLE ORBIMED ADVISORS LLC 9.89% view
S 2020-02-13 16:27:28.0 Aeglea BioTherapeutics AGLE Nantahala Capital Management 9.8% view
S 2020-02-13 16:17:30.0 Aeglea BioTherapeutics AGLE Lilly Ventures Fund I LLC 9.1% view
S 2020-02-12 16:12:59.0 Aeglea BioTherapeutics AGLE ADAGE CAPITAL PARTNERS GP 5.07% view
S 2020-02-06 14:01:04.0 Aeglea BioTherapeutics AGLE PRUDENTIAL FINANCIAL INC 0.1% view
B 2020-02-05 11:25:52.0 Aeglea BioTherapeutics AGLE BlackRock Inc 6.6% view
S 2020-02-03 14:43:43.0 Aeglea BioTherapeutics AGLE JENNISON ASSOCIATES LLC 0.0% view
S 2020-01-30 16:12:04.0 Aeglea BioTherapeutics AGLE Novartis Bioventures Ltd 2.13% view
S 2019-02-14 06:08:19.0 Aeglea BioTherapeutics AGLE Nantahala Capital Management 10.5% view
B 2019-02-13 16:29:16.0 Aeglea BioTherapeutics AGLE BAKER BROS 7.2% view
B 2019-02-12 17:42:44.0 Aeglea BioTherapeutics AGLE ORBIMED ADVISORS LLC 9.04% view
B 2019-02-07 18:09:33.0 Aeglea BioTherapeutics AGLE BlackRock Inc 5.4% view
B 2019-02-05 16:06:29.0 Aeglea BioTherapeutics AGLE Novartis Bioventures Ltd 5.2% view
S 2019-01-31 16:37:17.0 Aeglea BioTherapeutics AGLE PRUDENTIAL FINANCIAL INC 5.7% view
S 2019-01-31 11:20:52.0 Aeglea BioTherapeutics AGLE JENNISON ASSOCIATES LLC 5.6% view
* Institutions do not report transaction buy/sell types directly. To help members better understand the transactions, this column is filled by InsiderCow's best-effort interpretations.